ITPKC and invasive breast carcinoma: There was no significant difference in ITPKC expression by the American Joint Committee on Cancer (AJCC) cancer staging (Stage I–IV) and Nottingham grading system (Grade I, II and III) in a TCGA breast invasive carcinoma (BRCA) cohort (p = 0.681 and p = 0.824, respectively).